Read the article at Now Toronto
In the last couple of years, there’s been a rising interest in western medicine to incorporate psychedelic drugs like LSD, psilocybin (the active ingredient in magic mushrooms), MDMA and ketamine into therapeutic methodologies. Last year, the University of Toronto Mississauga launched the Psychedelic Studies Research Program, which explores the benefits of microdosing. Meanwhile clinical trials at New York University and Johns Hopkins have found psychedelics can help alleviate PTSD, anxiety and depression. The idea broke into the mainstream in 2018, when Michael Pollan released How To Change Your Mind: What The New Science Of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression and Transcendence…
